Linda Johnson

AP Business Writer
More from Linda Johnson
In this Tuesday, Feb. 26, 2019 file photo, Albert Bourla, chief executive officer of Pfizer, prepares to testify before the Senate Finance Committee hearing on drug prices, on Capitol Hill in Washington. On Thursday, Oct. 1, 2020, Bourla wrote to Pfizer employees that he's “disappointed” the timing for a vaccine to be available was politicized during Tuesday night’s presidential debate, saying the company won’t succumb to political pressure.
Pfizer CEO Pushes Back on Vaccine Timing
He's disappointed that the company's work is being politicized and reassured staff that he won’t bend to pressure to move more quickly.
Oct 2nd, 2020
This Oct. 21, 2019, photo shows Johnson's Baby Aloe & Vitamin E Powder in Salt Lake City. Johnson & Johnson reports financial results Tuesday, April 14, 2020. Johnson & Johnson is ending production of its iconic talc-based Johnson’s Baby Powder, which has been embroiled in thousands of lawsuits claiming it caused cancer. The world’s biggest maker of health care products said Tuesday, May 19, 2020 that the discontinuation only affects the U.S. and Canada, where demand has been declining.
J&J to Stop Selling Talc-Based Baby Powder in US
The company says the decline in demand for these products in North America has been "fueled by misinformation."
May 19th, 2020
This photo provided by Novo Nordisk Inc. shows its Tresiba brand insulin. On Tuesday, April 14, 2020, Novo Nordisk announced a new program offering free insulin for at least three months months for diabetes patients who have lost their insurance amid the COVID-19 pandemic.
Insulin Makers Offer Drug Free, or Cheap
All top three insulin makers are now offering programs to help patients.
Apr 15th, 2020
This Oct. 21, 2019, photo shows Johnson's Baby Aloe & Vitamin E Powder in Salt Lake City. Johnson & Johnson reports financial results Tuesday, April 14, 2020.
J&J Races to Develop Vaccine
The company also slashed its 2020 sales forecast by billions of dollars.
Apr 14th, 2020
This undated photo provided by the U.S. Attorney's Office shows a phony coronavirus cure that a British man tried to smuggle into the United States. Con artists are finding lots of marks amid the COVID-19 pandemic. Watchdog groups and authorities report a surge of complaints about scams targeting people who fear catching the virus or need money due to lost income.
COVID-19 Cure Cons Run Rampant
Americans filed complaints about losses to coronavirus-related fraud totaling nearly $6 million.
Apr 8th, 2020
In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. On Tuesday, March 24, 2020, the U.S. Food and Drug Administration warned the public about malfunctions involving some EpiPens, the emergency injectors for severe allergic reactions.
Malfunctioning EpiPens Could Harm Patients
The malfunctions can prevent or delay the devices from injecting the drug or cause them to eject it prematurely.
Mar 25th, 2020
Ap20076688184835
Hospitals Fear Ventilator Shortages
Up to 960,000 coronavirus patients in the U.S. may need ventilators. The nation has 200,000.
Mar 18th, 2020
This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md.
US Warns Over Fraudulent Coronavirus Claims
The companies are selling soaps, sprays and other concoctions with false claims that they can treat the new coronavirus or keep people from catching it.
Mar 10th, 2020
Ap20059626071119
FDA Says Drug Shortage Tied to Virus Outbreak
They declined to identify the manufacturer or the product.
Mar 2nd, 2020
This undated image provided by Eisai in August 2018 shows the company's Belviq medication.
Weight Loss Drug Pulled Over Cancer Risk
Despite the FDA's ruling, the manufacturer feels the drug’s benefits outweigh any risks.
Feb 14th, 2020
Ap20037184051734
Chinese Scientists Ask for Patent on US Drug
The country has the right under WTO rules to declare an emergency and compel a company to license a patent to protect the public.
Feb 6th, 2020
This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck is posting a 29% jump in fourth-quarter profit and it's spinning off its women's health division and other operations that churn out $6.5 billion in annual revenues. The drugmaker on Wednesday, Feb. 5, 2020 reported net income of $2.36 billion, up from $1.83 billion, a year earlier.
Merck Spins Off
It's spinning off its women's health division and other operations.
Feb 5th, 2020